HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is significantly less frequent in ependymal tumours as compared to malignant astrocytic gliomas.

AuthorsB Koos, S Peetz-Dienhart, B Riesmeier, M C Frühwald, M Hasselblatt
JournalNeuropathology and applied neurobiology (Neuropathol Appl Neurobiol) Vol. 36 Issue 4 Pg. 356-8 (Jun 2010) ISSN: 1365-2990 [Electronic] England
PMID20202118 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Tumor Suppressor Proteins
  • DNA Modification Methylases
  • MGMT protein, human
  • DNA Repair Enzymes
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Astrocytoma (genetics, pathology)
  • Child
  • Child, Preschool
  • DNA Methylation
  • DNA Modification Methylases (genetics)
  • DNA Repair Enzymes (genetics)
  • Ependymoma (genetics, pathology)
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Promoter Regions, Genetic
  • Tumor Suppressor Proteins (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: